Wolters Kluwer Health - Lippincott Williams & Wilkins

Registered Users

User Name:
Password:
Register   Forgotten Password
Enter your email address:
  • Conferences
  • Free Content
  • Hot Topics
  • News
  • Archive
  • Contact Us
  • Home
  • Free Content
  • Hot Topics
  • News
  • Podcasts
  • About Us
  • Contact Us
  • Publish With Us
  • Conferences
  • Register

Banner image: Anaesthesiology Focus

You are here: Home » Oncology » Acidic catalase in human skin in vivo

Acidic catalase in human skin in vivo: a new marker of permanent damage

Image of the cover of Melanoma ResearchMaresca et al
Melanoma Research:19(6) December 2009
ISSN: 0960-8931 • Frequency: 6/year • Impact Factor: 2.336 • Subscribe Now

Malignant melanoma incidence is increasing rapidly in Western countries. Its prevention requires a deep knowledge of the biological basis of the neoplasm leading to the identification of new biological risk markers. In in-vitro and ex-vivo models we demonstrated that catalase was modified not only in its activity but also in its charge properties after ultraviolet A irradiation through pheomelanin. Here we focus on the electrophoretic behaviour of catalase in the human skin in vivo, in association with cutaneous phototype. Zymographic analysis of the enzyme on skin biopsies from Caucasian population (phototype I-IV), collected from the trunk in autumn-winter, to exclude possible influences of an acute photoexposure, evidenced a protein doublet, representing the coexistence of two active isoforms of catalase with different charge properties. In the skin from low-phototype subjects, the percent contribution of the more acidic component of the doublet was prevalent, inversely correlated with total melanin concentration in hair, and associated with a high number of melanocytic nevi. In summary, this study shows for the first time the existence of an acidic catalase in association with clinically defined risk characteristics in low phototype skin in vivo, contributing to the knowledge of a new biochemical marker of cutaneous photosusceptibility.

Read a special Authors introduction to this article 
Read this Article

 

 


 

Don't miss out - further Free LWW Content is available for registered users! Log into your account or register here to read these articles

Cover image of Anti-Cancer DrugsHematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia
Zuckerman and Rowe • Anti-Cancer Drugs

ISSN: 0959-4973 • Frequency: 10/year • Impact Factor: 2.358 • Subscribe Now

 

 

 

 

 

 

Bookmark and Share







Conferences


©2010 Lippincott Williams & Wilkins
Judd Associates: Sussex Web Design
  • Site Map
  • Accessibility
  • Privacy
Follow us on Facebook and Twitter